Meet Our Leadership Team
FRANK G. HOWARD
Founder & Chief Executive Officer
Frank earned his B.A. in Economics from Southern Methodist University and has led successful molecular diagnostic testing laboratories for 8 years, serving vast amounts of clients throughout North America. He is also the founder and CEO of the Gulfstream Companies (Gulfstream Health and Gulfstream Capital). Gulfstream's focus is on opportunistic private debt and equity transactions, and its subsidiaries have deployed in excess of $400m of equity across 75+ investments throughout the United States. Gulfstream has a diverse asset base of passive and active investments focused in healthcare.
ANDRE L. JOHNSON
Chief Administrative Officer
Andre has more than 20 years of professional experience in human resources, including training and development for startup, nonprofit and publicly traded organizations. He oversees all human capital and administrative operations.
Vice President of Sales
Bobby has more than 17 years of proven Sales and Operations experience in the laboratory industry. Prior to joining geneIQ, he was Vice President of Strategic Accounts at NeoDiagnostix, a leader in cervical cancer genomics. Aside from owning his own clinical lab for several years, prior to an acquisition by Quest Diagnostics, he has held several sales leadership positions in the clinical lab space.
Director of Long-Term Care
Stacy has been a leader in the Senior Care Industry for over 20 years.
As a licensed long-term care home administrator, she has supported and served thousands of residents, families and teams through their journey in Senior Care. She started in the business at age 23 and has built and grown many programs and organizational cultures along the way.
Senior VP of Operations
Dru has over 18 years of combined leadership experience working at IBM, Olympus Corporation of the Americas, and Inform Diagnostics. Dru led Client Services, Lab Operations, Medical Operations, Process Improvement, Continuous Improvement, Inside Sales, External I.T., and Client Retention at Inform Dx, one of the larger anatomic pathology labs in America. Prior to joining Inform Dx, Dru lead the Customer and Sales Support departments at Olympus, the largest endoscopy equipment provider in the world, for 10 years.
JOHN R. HARRIS
Board of Directors and Advisor
John Harris is a veteran investor, advisor, board member and recognized executive in the Information Technology and Business Services Industries with more than 35 years of experience in CEO and senior leadership positions. Earlier in his career, Harris spent twenty-five years with Electronic Data Systems (“EDS”), during which time he held a variety of executive leadership positions including Group Executive, Corporate Officer and President of EDS’ four strategic business units serving the telecommunication and media industries worldwide. In addition, John has served on numerous private and public board of directors as Chairman, Lead director, and Special Committee Chairman, as well as Chairing Audit, Compensation and Governance committees. Harris holds a Master of Business Administration and a Bachelor of Business Administration from the University of West Georgia and is on the Board of Advisors to the Richardson School of Business.
Client Development Executive
JD is a healthcare professional with over 10 years of experience in post acute care, skilled nursing rehabilitation, home health, hospice and laboratory. He is a graduate of Harding University with a B.S. in Kinesiology and a B.B.A. in Marketing.
Director of Communications and Media
Marisa graduated with an arts degree from the University of Texas and has worked as a creative for over 10 years in various roles. She focuses on all marketing and design, so that GeneIQ is cohesively branded and capable of cobranding with any of its affiliated partners. She also coordinates all press, media, and advertising campaigns.
National Accounts Manager
Mark has worked in a variety of industries over his career and has spent the Iast 12 years in and around the healthcare industry. His healthcare assignments have included CPT/ICD coding accuracy improvement, medical record documentation completeness, and medical lien specialty finance. As an award-winning entrepreneur, Mark led one of his companies to be named Virginia's Business of the Year.
Revenue Cycle Management Director
Amber brings more than 20 years of experience in the laboratory industry with expertise in revenue cycle management and operations. She supervises all billing, collections, and customer service operations.
Meet Our Scientific Leaders
DR. TARIQ ADWAN PhD
Chief Scientific Officer
Dr. Adwan graduated with honors from Misericordia University with a B.S. in Biology and Chemistry. He received his Ph.D. in Cell Biology, Stem Cells and Development from the University of Colorado where he also did his postdoctoral fellowship. His research focused on understanding the molecular mechanism underlying salivary gland dysfunction in head and cancer patients. While a graduate student and postdoctoral fellow, Dr. Adwan received numerous grants and awards including the National Research Service Award from the National Institute of Health. In addition, Dr. Adwan is co-author of numerous high-impact, peer reviewed publications. He has been invited to present his work at various scientific meetings including the conference for the Federation of American Societies for Experimental Biology on Lipid Mediated Signaling in Cancer. Before joining our team, Dr. Adwan worked as an assistant professor at An-Najah National University, in their School of Medicine.
DR. TABETHA SUNDIN PhD, HCLD (ABB), MB (ASCP)CM
Dr. Sundin graduated from Old Dominion University where she completed her B.S. in Biology, Ph.D. in Biomedical Sciences, and Postdoctoral Fellowship. She has over 10 years of laboratory experience in cancer biology and clinical molecular diagnostics and is an active member of the Association of Molecular Pathology (AMP). She is widely published and speaks at various symposiums about multidisciplinary facilitation of biomarker testing in cancer patients on behalf of AstraZeneca and Bristol-Myers Squibb. She’s involved with numerous efforts to support the molecular diagnostics field in collaboration with American Medical Technologists (AMT) and the Clinical & Laboratory Standards Institute (CLSI).
Samantha earned her B.S. in Microbiology from the University of Texas at Austin and is a certified Technologist in Molecular Biology from the American Society for Clinical Pathology. Samantha provides supervision of daily laboratory functions and testing personnel to ensure the proper performance of all laboratory procedures, as well as the highest quality of service to clients.
Aleksandra graduated from Purdue University with a degree in Biology and supervises all accessioning operations in the laboratory.